Pure Global

"Haifeng Biomedical" Rivaroxaban quality control liquid group - Taiwan Registration 3a8e76327d50d216a63d3757825b5821

Access comprehensive regulatory information for "Haifeng Biomedical" Rivaroxaban quality control liquid group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3a8e76327d50d216a63d3757825b5821 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3a8e76327d50d216a63d3757825b5821
Registration Details
Taiwan FDA Registration: 3a8e76327d50d216a63d3757825b5821
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Haifeng Biomedical" Rivaroxaban quality control liquid group
TW: โ€œๆตทๅฅ‰็”Ÿ็‰ฉ้†ซๅญธโ€Rivaroxabanๅ“็ฎกๆถฒ็ต„
Risk Class 2

Registration Details

3a8e76327d50d216a63d3757825b5821

DHA05603418503

Company Information

France

Product Details

This product contains different concentrations of Rivaroxaban lyophilized human plasma for quality control of Rivaroxaban measurement.

A Clinical chemistry and clinical toxicology

A.1660 Quality control materials (analytical and non-analytical)

Input;; QMS/QSD

Dates and Status

Jan 06, 2021

Jan 06, 2026